Related Experiment Video
Updated: Mar 13, 2026
07:00
A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene
Published on: April 1, 2019
10.5K
TRPA1 gene polymorphisms and childhood asthma
Valentina Gallo1, F Nicole Dijk2, John W Holloway3
1Centre for Primary Care and Public Health, Barts and The London School of Medicine and Dentistry, London, UK.
Summary
The transient receptor potential ankyrin-1 (TRPA1) ion channel is linked to childhood asthma development. Gene variants in TRPA1 show significant associations with asthma in multiple birth cohorts.
Area of Science:
- Genetics
- Immunology
- Respiratory Medicine
Background:
- Animal studies suggest the TRPA1 ion channel is involved in airway inflammation and asthma.
- Human data linking TRPA1 to asthma and paracetamol effects are limited.
- TRPA1's role in childhood asthma requires further investigation.
Purpose of the Study:
- To investigate associations between TRPA1 gene variants and childhood asthma.
- To examine the relationship between TRPA1 gene variants and total IgE levels.
- To explore interactions between TRPA1 and prenatal paracetamol exposure on asthma and IgE.
Main Methods:
- Analysis of 31 TRPA1 single nucleotide polymorphisms (SNPs) in the ALSPAC birth cohort.
- Validation of significant associations in the PIAMA and Generation R birth cohorts.
- Exploration of gene-environment interactions with prenatal paracetamol exposure in ALSPAC.
Main Results:
- Six TRPA1 SNPs were significantly associated with childhood asthma in the ALSPAC cohort.
- Meta-analysis across three cohorts confirmed significant associations for these six SNPs with asthma.
- TRPA1's association with asthma was not modified by prenatal paracetamol, but IgE associations were.
Conclusions:
- TRPA1 gene variants are associated with childhood asthma.
- The TRPA1 ion channel may contribute to the pathogenesis of childhood asthma.
- Further research is warranted to elucidate TRPA1's specific role in asthma development.
Related Concept Videos
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
61
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
61
01:26Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
01:29Asthma-I: Introduction
3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
01:20Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
83
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
83
01:19Antiasthma Drugs: Leukotriene Modifiers
2.1K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
2.1K